{"filings":[{"id":1388119,"accession_number":"0001104659-26-079874","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-07-01T20:15:45+00:00","items":["5.02"],"status":"ready","headline":"Astrana Health CAO Glenn Sobotka to retire; John Vong to succeed as principal accounting officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Glenn Sobotka will retire as Chief Accounting Officer effective August 7, 2026; no disagreement with company.","John Vong, currently SVP – Accounting, will become principal accounting officer on August 7, 2026.","Vong previously served as CAO from Nov 2022 to Mar 2025; his annual base salary will increase to $320,000 effective July 1, 2026.","Vong's target bonus percentage for 2026 remains unchanged; no family relationships or material transactions disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":973079,"accession_number":"0001104659-26-072343","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-06-10T20:15:42+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Astrana Health shareholders approve 1M-share increase to 2024 equity plan, re-elect all nine directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing shares reserved by 1,000,000 to a total of 5,100,000 shares.","All nine director nominees were elected, including Kenneth Sim, Thomas Lam, John Chiang, Weili Dai, Linda Dong, J. Lorraine Estradas, Mitchell Kitayama, Matthew Mazdyasni, and David Schmidt.","Ernst & Young was ratified as independent auditor for FY 2026 with 43.7M votes for, and the say-on-pay proposal passed with 34.1M votes for.","The share reserve increase extends the plan term to March 24, 2036; the plan originally effective from 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":21802,"accession_number":"0001104659-26-058922","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-05-12T10:06:08+00:00","items":["5.02"],"status":"ready","headline":"Astrana Health CMO Dinesh Kumar resigns effective June 1, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dinesh Kumar, M.D., Chief Medical Officer, notified resignation on May 7, 2026.","Resignation effective June 1, 2026; no stated reason other than personal intention.","Company confirms resignation is not due to any disagreement with Astrana Health.","No successor named; CEO Brandon K. Sim signed the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":21805,"accession_number":"0001104659-26-058914","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-05-12T10:03:42+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health updates investor presentation with Q1 2026 metrics and FY2026 outlook","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation includes G&A efficiency chart with data for FY2023-FY2026E and Q1 2025/Q1 2026.","Revenue mix shown across Medicare, Medicaid, Commercial, and other risk arrangements.","No specific financial guidance changes disclosed; presentation used for conferences.","Company does not undertake to update the presentation content beyond this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91167,"accession_number":"0001104659-26-057134","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Astrana Health Q1 revenue up 56% to $965M; adjusted EBITDA up 82% to $66.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $965.1M, up 56% YoY; Care Partners revenue $909.7M, up 51%.","Net income attributable to Astrana $14.4M, up 116%; diluted EPS $0.29, up 107%.","Adjusted EBITDA $66.3M, up 82%; adjusted diluted EPS $0.74, up 76%.","Net cash from operations $68.1M (up 309%); free cash flow $64.1M (up 372%)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":965100000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101115,"accession_number":"0001104659-26-036862","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Astrana Health files interim financials of acquired Prospect entities; pro forma included","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquired Business (PHPH & RI Market) nine-month net loss $38.7M vs $43.7M year-ago; total net revenue $961.8M (+9.6% YoY).","Operating income $48.5M vs $88.4M YoY; interest expense $121.8M drove pre-tax loss $73.4M.","Members' deficit $1.31B as of June 30, 2025, with long-term debt $777.8M and current debt $489.0M.","Pro forma condensed combined statement of operations for Astrana for fiscal year 2025 filed as Exhibit 99.2."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101114,"accession_number":"0001104659-26-023176","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health expects material weakness in internal controls; 10-K filing by extension deadline","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Updated investor presentation furnished; no specific new financial or strategic details.","Forward-looking statements disclose expected material weakness in internal control over financial reporting for FY2025.","Company expects to file 2025 Form 10-K on or before extended due date following Form 12b-25.","Warns that financial statements in 10-K may differ from prior earnings release information."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101113,"accession_number":"0001104659-26-021893","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"Astrana Health FY2025 revenue $3.18B (+56% YoY), adjusted EBITDA $205.4M; material weakness delays 10-K filing","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2025 total revenue $3.18B (+56% YoY); at high end of guidance; Care Partners revenue $3.02B (+55%).","Adjusted EBITDA $205.4M (+21% YoY); adjusted diluted EPS $2.20; net income $22.5M, GAAP EPS $0.46.","Q4 revenue $950.5M (+43% YoY); adjusted EBITDA $52.5M (+50%); adjusted EPS $0.54.","Board doubled share repurchase authorization to $100M; $35.9M remained at Dec 31, 2025.","Anticipates material weakness in internal controls over acquisition/purchase accounting; expects to file 10-K within 15-day extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101112,"accession_number":"0001104659-26-002866","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health furnishes updated investor presentation; no material new information disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Corporate presentation updated effective January 12, 2026, for use at conferences and meetings.","No new financial results, earnings guidance, or business developments were disclosed.","Filing contains no material changes to the company's strategy or operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117455,"accession_number":"0001104659-25-107754","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Astrana Health Q3 revenue $956M (+100% YoY); adjusted EBITDA $68.5M; closes Prospect Health","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $956.0M, up 100% YoY; Care Partners revenue $897.7M, up 97%.","Adjusted EBITDA $68.5M, up 52% YoY; net income $0.4M, diluted EPS $0.01.","Closed Prospect Health acquisition; standalone Q3 performance exceeded expectations.","Full-year 2025 guidance updated for full-risk contract delays; expects completion in Q1 2026.","Reiterating full-year medical cost trend expectations; underlying performance strong."],"consensus_eps_estimate":0.4501,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2231243000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133861,"accession_number":"0001104659-25-089230","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K/A","filed_at":"2025-09-11T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Acquired PHP Holdings reports FY2024 net loss of $78.7M on $1.19B revenue; high leverage","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["PHP Holdings net loss $78.7M in FY2024 vs net income $30.5M in FY2023, driven by $138.3M interest expense.","Total revenue $1.19B in FY2024, up 14.5% from $1.04B in FY2023; gross margin $324.6M.","Total assets $296.6M, total liabilities $1.49B, members' deficit $1.27B as of Sep 30, 2024.","Long-term debt $1.13B, including PIK interest; operating income only $103.8M.","Astrana Health (ASTH) closed acquisition Jul 2, 2025; pro forma financials filed as Exhibit 99.3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133863,"accession_number":"0001104659-25-075194","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health Q2 revenue $654.8M, +35% YoY; adjusted EBITDA $48.1M, guidance reiterated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $654.8M, up 35% from $486.3M; adjusted EBITDA $48.1M, both at higher end of guidance.","Net income $9.4M, EPS-diluted $0.19; six-month EPS $0.33.","Care Partners revenue $631.4M, up 36% YoY.","Reiterates full-year 2025 guidance, inclusive of completed Prospect Health acquisition.","Medical cost trends within expectations across all lines of business."],"consensus_eps_estimate":0.3704,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":1275196000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133862,"accession_number":"0001104659-25-065009","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["1.01","2.01","2.02","7.01","9.01"],"status":"ready","headline":"Astrana closes Prospect Health acquisition for $708M, updates FY 2025 guidance","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price reduced from $745M to $708M; closed July 1, 2025.","Expects Prospect to contribute ~$1.2B revenue and $81M adjusted EBITDA annually.","Updated FY 2025 guidance: revenue $3.1B-$3.3B, adjusted EBITDA $215M-$225M.","Post-close net debt ~$700M; target net leverage below 2.5x within 12-18 months.","Reiterates Q2 2025 guidance; expects $12M-$15M synergies over 12-18 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150604,"accession_number":"0001104659-25-058542","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-06-11T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Astrana Health shareholders approve amended equity plan; Weili Dai receives nearly 50% withheld votes","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved increase of 2,000,000 shares under 2024 Equity Incentive Plan (total 4,100,000 shares reserved).","Term of 2024 Plan extended to March 25, 2035.","All nine director nominees elected; Weili Dai received 19,196,569 withheld vs 18,977,644 for (approx. 50% withheld).","Ernst & Young LLP ratified as independent auditor for fiscal 2025 (42,631,420 for, 260,880 against).","Advisory vote on executive compensation passed: 34,713,926 for, 3,370,998 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150603,"accession_number":"0001104659-25-056164","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health updates corporate investor presentation; details not provided","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company furnished updated corporate presentation as Exhibit 99.1 for use at conferences and meetings.","Presentation slides attached to Form 8-K, but specific new data or guidance not disclosed in the filing.","No earnings, M&A, leadership, or other material operational changes announced in this report.","Presentation update is routine; no forward-looking statements revised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150602,"accession_number":"0001104659-25-047838","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health furnishes updated corporate presentation; no material new data","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company posted an updated investor presentation dated May 2025 for conference use.","Presentation slides are provided as Exhibit 99.1; no specific financial targets or guidance changes disclosed.","Filing is purely procedural under Regulation FD; no new operational or financial metrics released."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150601,"accession_number":"0001104659-25-046125","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health Q1 revenue up 53% to $620M; net income down to $6.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $620.4M (+53% YoY); Care Partners revenue $601M (+57%).","Net income attributable to Astrana $6.7M vs $14.8M; diluted EPS $0.14 vs $0.31.","Adjusted EBITDA $36.4M vs $42.2M; margin contraction despite revenue growth.","CEO cites momentum in value-based care model and strong start to 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":620390000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169561,"accession_number":"0001104659-25-028969","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-03-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Astrana Health appoints Glenn W. Sobotka as Chief Accounting Officer (CAO), effective March 26, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Vong transitions to a new role and ceases as principal accounting officer on the same date.","Sobotka receives annual base salary of $320,000, discretionary bonus target of 40%, 6,432 shares of restricted stock (4-year annual vest), and 8,269 performance-based RSUs.","Sobotka previously served as CAO at Carbon Health and agilon health, and CFO at Arkos Health.","If terminated without cause or for good reason, Sobotka is entitled to severance benefits subject to a release of claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169554,"accession_number":"0001104659-25-023741","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K/A","filed_at":"2025-03-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health files 8-K/A correcting preliminary FY2024 balance sheet; goodwill down $18.4M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Goodwill decreased by $18.4M (from $437.7M to $419.3M) due to Q4 acquisition adjustments.","Other receivables increased by $25.8M; intangible assets net decreased by $8.0M; accounts payable down $8.5M.","Revisions have no impact on FY2024 income statements or FY2025 guidance issued Feb 27, 2025.","Corrected balance sheet and supplemental data furnished; VIE footnote updated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169560,"accession_number":"0001104659-25-021981","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health updates corporate presentation; no material new information disclosed","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Updated presentation filed as Exhibit 99.1 for use in conference and investor meetings.","No financial guidance, operational metrics, or strategic changes announced.","Filing is a routine update under Regulation FD; no forward-looking statements revised."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169559,"accession_number":"0001104659-25-019499","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health updates corporate presentation; no specific details provided in filing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed under Item 7.01; presentation attached as Exhibit 99.1 is not reproduced in the filing text.","Presentation intended for use at conferences and meetings; no financial or operational targets disclosed.","Company does not undertake to update the presentation materials; forward-looking statements included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169558,"accession_number":"0001104659-25-018268","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health FY2024 revenue up 47% to $2.03B, net income down 29% to $43.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $2,034.5M (+47% YoY); Care Partners revenue $1,949.0M (+52%).","Net income attributable to Astrana $43.1M (down from $60.7M); diluted EPS $0.90 (vs $1.29).","Adjusted EBITDA $170.4M, up 16% from $146.6M.","Company to host conference call Feb 27 at 5:30 p.m. ET."],"consensus_eps_estimate":null,"consensus_eps_actual":0.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":2034540000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169557,"accession_number":"0001104659-25-018221","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Astrana Health enters $1.295B credit facility; $745M delayed draw for Prospect acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Five-year $300M revolver, $250M term A loan, and $745M delayed draw term loan.","Delayed draw term loan to finance acquisition of assets from Prospect Medical Holdings (agreement Nov 8, 2024).","Covenants: max total net leverage 5.00x (falling to 4.50x after Mar 2027); min interest coverage 2.50x.","Borrower and subsidiary Astrana Health Management grant security interest in all assets to lenders.","Annual meeting set for June 11, 2025; virtual; record date April 22, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169556,"accession_number":"0001104659-25-004739","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-01-21T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Astrana Health repurchases 300,000 shares from affiliate APC for $10.6M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Repurchased 300,000 shares at $35.17 each, aggregate $10.55M, based on Jan 17 closing price.","Seller APC is a consolidated affiliate; Dr. Kenneth Sim (Executive Chairman) and Dr. Thomas Lam (Vice Chairman) hold roles at both.","Transaction approved by Astrana's Board and Audit Committee; structured as exempt private resale under Section 4(a)(1½).","Repurchase reduces Astrana's outstanding shares by 300,000, returning capital to a related party at market price."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169555,"accession_number":"0001104659-25-003293","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health: Prospect Medical Ch. 11 filing excludes acquisition assets; deal unaffected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Prospect Medical Holdings filed for Chapter 11 bankruptcy on January 11, 2025, in the Northern District of Texas.","Businesses and assets being acquired by Astrana are not included in the bankruptcy filing.","Astrana expects no impact on the timing or completion of the previously announced acquisition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186613,"accession_number":"0001104659-24-118357","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health files 8-K furnishing investor presentation for upcoming conferences","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Astrana Health (ASTH) filed an 8-K on Nov 14, 2024, disclosing a slide presentation (Exhibit 99.1) for use at upcoming conferences.","The presentation contains financial information about Astrana Health, but no specific numbers or guidance are provided in the filing.","The 8-K includes forward-looking statements and cautionary notes regarding risks detailed in prior SEC filings.","CEO Brandon K. Sim signed the report; the presentation is furnished under Item 7.01 and not deemed filed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186612,"accession_number":"0001104659-24-116826","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Astrana Health grants one-time equity awards to Chairman, CEO, COO/CFO, and CMO to boost retention","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Kenneth Sim: 200,000 restricted shares (133,333 performance, 66,667 time-based).","Brandon Sim: 104,200 RSUs (69,814 performance, 34,386 time-based).","Chandan Basho: 47,000 RSUs (31,490 performance, 15,510 time-based).","Thomas Lam: 40,000 restricted shares (26,667 performance, 13,333 time-based).","Dinesh Kumar: 67,238 performance-based restricted shares tied to partner integration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186611,"accession_number":"0001104659-24-115969","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Astrana Health to acquire hospital, health plan & ACO for $745M; arranges $1.195B financing","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires equity of Prospect Health Plan, Alta Newport Hospital (Foothill Regional), and Prospect ACO Rhode Island for $745M.","Financing includes $1.095B bridge term loan (364-day) and $100M revolver from Truist and JPMorgan.","Transaction expected to close mid-2025, subject to regulatory approvals and customary conditions.","Acquired entities provide managed care, physician networks, and acute hospital services across risk-based models."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186610,"accession_number":"0001104659-24-115610","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health to acquire Prospect Health for $745M; adds ~610k members","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price of $745 million plus assumption of certain liabilities; expected close mid-2025 subject to regulatory approval.","Prospect generates ~$1.2B revenue and ~$81M adjusted EBITDA for trailing twelve months ending Dec 2024.","Astrana secured $1,095M bridge loan commitment from Truist and JPMorgan, plus $100M revolver, to fund the deal.","Acquisition adds 3,000 primary care and 10,000 specialist providers across CA, TX, AZ, and RI.","Combined entity expected to serve ~1.7 million members across Medicare, Medicaid, and Commercial lines."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186609,"accession_number":"0001104659-24-115381","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health Q3 revenue up 37% to $478.7M; net income down 27% to $16.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net income $16.1M (-27% YoY); diluted EPS $0.33 (-30%); adjusted EBITDA $45.2M (-13%).","Care Partners revenue $455.8M (+42% YoY); total revenue $478.7M (+37%).","Closed acquisition of Collaborative Health Systems for $37.5M plus up to $21.5M earnout on Oct 4.","FY2024 guidance raised: revenue $1.95B-$2.03B, adjusted EBITDA $165M-$175M, EPS $1.06-$1.19.","Nine-month revenue $1.37B (+32%); net income $50.1M (+4%); adjusted EBITDA $135.3M (+15%)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":1369331000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186608,"accession_number":"0001104659-24-106504","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-10-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Astrana Health completes acquisition of Collaborative Health Systems and affiliates","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Closed acquisition of Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks on Oct 4, 2024.","Deal had been previously announced; no additional financial terms or details disclosed in this filing.","Acquisition expands Astrana Health's network and capabilities in value-based care."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203183,"accession_number":"0001104659-24-096952","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-09-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health furnishes investor presentation for conferences; no specific financial data disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Slides for upcoming conference presentations provided as Exhibit 99.1.","Presentation does not contain new financial guidance or material operational updates.","Information is furnished per Item 7.01 and not incorporated by reference."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203182,"accession_number":"0001104659-24-086761","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health Q2 revenue up 40% to $486.3M, EPS $0.40; acquires CHS from Centene","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $486.3M (+40% YoY), net income $19.2M (+46%), diluted EPS $0.40 (+43%), adjusted EBITDA $47.9M (+34%).","Six-month revenue $890.6M (+30%), net income $34.0M (+29%), diluted EPS $0.71, adjusted EBITDA $90.2M (+38%).","Entered Arizona via partnership with 45+ PCP group; Hawaii via Elation Health partnership covering ~20K Medicare patients.","Definitive agreement to acquire Collaborative Health Systems from Centene (~2,500 PCPs, 100K+ beneficiaries) expected Q4 2024.","Updated FY2024 revenue guidance $1.75B-$1.85B; reiterated adjusted EBITDA $165M-$185M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":890621000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203181,"accession_number":"0001104659-24-082519","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Astrana Health to acquire Collaborative Health Systems from Centene for $37.5M plus up to $21.5M earnout","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $37.5M plus earnout up to $21.5M for CHS, GTPA, and HPN.","CHS serves 129,000 beneficiaries across 17 states; includes 350+ PCPs in Texas.","Expected closing by year-end, subject to customary regulatory approvals.","Acquisition expands Astrana's payer-agnostic care delivery; Centene remains a key partner."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203180,"accession_number":"0001104659-24-079867","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Astrana registers Earn-Out Shares for resale; no proceeds to company","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed prospectus supplement on July 15, 2024 for resale of Earn-Out Shares.","Earn-Out Shares are contingent consideration from October 2022 acquisition of AAMG.","Company will not receive any proceeds from the resale of the shares.","Thompson Hine LLP opinion on validity filed as Exhibit 5.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219504,"accession_number":"0001104659-24-071275","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-06-13T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Astrana Health files certificate amendment to exculpate officers under Delaware law","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment to restated certificate of incorporation approved by stockholders on June 12, 2024.","Exculpates certain officers from liability for stockholder claims as permitted by DGCL Section 102(b)(7).","Certificate of Amendment filed with Delaware Secretary of State effective June 13, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219503,"accession_number":"0001104659-24-070847","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-06-12T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve 2024 Equity Incentive Plan adding 2.1M shares; all director nominees elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine director nominees elected at June 12 annual meeting; quorum of 75.6%.","2024 Equity Incentive Plan approved (37.1M for); authorizes 2.1M new shares, replacing 2015 Plan.","Advisory 'say-on-pay' passed (37.3M for); Ernst & Young ratified as auditor for FY 2024.","Charter amendment adding officer exculpation provisions approved.","Plan effective Feb 28, 2024; no changes to executive compensation or board composition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219502,"accession_number":"0001104659-24-063598","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Astrana Health amends credit agreement to allow letters of credit extending beyond maturity date","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Fourth Amendment to Amended and Restated Credit Agreement dated May 20, 2024, with Truist Bank as agent.","Amendment permits issuance of Post-Maturity LCs that expire after the Revolving Commitment Termination Date.","Borrower must deposit 105% cash collateral for Post-Maturity LCs five business days before the termination date.","Lenders include JPMorgan, Preferred Bank, Fifth Third, RBC, TD, Wells Fargo, City National."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219501,"accession_number":"0001104659-24-061405","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health furnishes investor presentation; no material new details evident","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Form 8-K filed under Item 7.01 with an investor presentation as Exhibit 99.1.","Presentation slides contain financial information for potential investor/analyst meetings.","No specific financial figures, guidance updates, or operational changes were disclosed in the filing text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219500,"accession_number":"0001104659-24-058018","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Q1 revenue $404.4M (+20% YoY), net income $14.8M (+13%), EPS $0.31","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $404.4M (+20% YoY); net income attributable $14.8M (+13%); diluted EPS $0.31 (+11%).","Adjusted EBITDA $42.2M (+42% YoY); full-year 2024 guidance reaffirmed: revenue $1.65-1.85B, adj. EBITDA $165-185M.","Completed largest acquisition (CFC) on Mar 31 and acquired PCCCV (~26K Medicaid members) on Mar 29.","Organic membership growth 10% YTD; total lives ~1M; full-risk capitation expected ~60% of total capitation revenue as of Apr 1.","Opened two new de novo clinics in Nevada in April."],"consensus_eps_estimate":null,"consensus_eps_actual":0.31,"consensus_revenue_estimate":null,"consensus_revenue_actual":404356000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219499,"accession_number":"0001104659-24-050973","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Astrana Health eliminates Series A and B preferred stock designations from charter","summary_kind":"llm","event_type":"other","confidence":"medium","bullets":["Filed Certificate of Elimination removing Series A and Series B Convertible Preferred Stock designations.","No shares of Series A or B preferred stock were outstanding as of April 24, 2024.","The shares revert to authorized but unissued preferred stock without series designation.","No impact on common stock or financials; purely administrative charter cleanup."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219498,"accession_number":"0001104659-24-050759","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Dr. Albert Young transitions from CAO to SVP of Health Affairs at Astrana Health","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Albert Young transitioned from CAO to SVP of Health Affairs effective April 23, 2024.","Compensation arrangements for Dr. Young remain unchanged following the transition.","No other officer changes or departures reported in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219497,"accession_number":"0001104659-24-043762","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-04-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Astrana Health amends CEO & COO/CFO employment pacts, grants $13M in equity","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Brandon Sim new base salary $850k, target bonus 125%; CFO Chandan Basho base $600k, target bonus 80%.","Equity grants: CEO $11M, COO $2M; 33% time-based RSUs, 67% performance-based (adj. EBITDA & revenue, 2024-2026).","Agreements have 3-year initial term through April 2027, with auto-renewal unless 60-day notice.","Severance: 1-year salary (or 2-year post-change of control) plus COBRA coverage for up to 12 months (24 months post-CIC)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219496,"accession_number":"0001104659-24-042549","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-04-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Astrana Health completes acquisitions of AHMS and 25% of I Health; purchase agreements amended","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Completed second closing on March 31, 2024, acquiring all partnership interests of Advanced Health Management Systems (AHMS).","Also closed on March 31 the acquisition of 25% of I Health, Inc. common stock under the Stock Purchase Agreement.","Amendment No. 2 sets AHMS Representative Fund at $3.45M and adds Buyer indemnification for DMHC undertakings.","Amendment No. 1 adjusts I Health purchase price (amount redacted), introduces holdback, and adds contingent payment tied to CFC Services Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239329,"accession_number":"0001104659-24-032624","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Astrana Health issues FY2024 revenue $1.65-1.85B, Adj. EBITDA $165-185M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FY2023 rev $1.39B, Adj. EBITDA $146.6M, diluted EPS $1.29.","FY2024 guidance: rev $1.65-1.85B, Adj. EBITDA $165-185M, EPS $1.28-1.52.","Closed CFC acquisition Jan 31, 2024; $202M total (cash $152M, equity $20M, milestones $30M).","10,000+ providers, ~900k VBC members; 48% fewer hospital admits vs benchmark.","Care Enablement segment long-term EBITDA margin target 20-30%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239328,"accession_number":"0001104659-24-028972","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Astrana Health amends bylaws for universal proxy; sets annual meeting June 12","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bylaws effective Feb 28, 2024, add universal proxy procedural mechanics per SEC Rule 14a-19.","White proxy card reserved exclusively for Board; other solicitations must use different color.","Annual meeting scheduled for June 12, 2024; record date is April 23, 2024.","Amendments conform to recent Delaware General Corporation Law updates and include ministerial changes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239327,"accession_number":"0001104659-24-028213","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Astrana Health FY2023 revenue $1.39B (+21%), net income $60.7M (+34%), EPS $1.29 (+30%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $1,386.7M, up 21% from $1,144.2M in 2022.","Net income attributable to Astrana $60.7M, up 34% from $45.2M.","Diluted EPS $1.29, up 30% from $0.99.","Adjusted EBITDA $146.6M, up 5% from $140.0M.","Care Partners revenue $1,300.1M, up 24% from $1,051.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":1386661000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239326,"accession_number":"0001104659-24-027198","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Apollo Medical Holdings renamed Astrana Health; ticker now ASTH","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change from Apollo Medical Holdings, Inc. to Astrana Health, Inc., effective February 26, 2024.","Common stock began trading under new ticker symbol 'ASTH' on The Nasdaq Stock Market on February 26, 2024.","Amended and restated bylaws reflect name change; no other substantive changes were made.","No financial impact; company operations remain unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239325,"accession_number":"0001104659-24-009754","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["3.02","8.01","9.01"],"status":"ready","headline":"Apollo Medical Holdings completes first closing of CFC asset acquisition; amends purchase agreement","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["First closing for CFC assets completed Jan 31, 2024; second closing for AHMS expected Q1 2024.","Purchase price ~$202M: $152M cash, $20M equity (631,712 shares), up to $30M milestone payments.","Amendment No. 1 modified definitions, covenants, and closing mechanics; adds Allied provisions.","I Health 25% stock purchase expected to close in Q1 2024, subject to regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239324,"accession_number":"0001104659-24-006988","cik":1083446,"company_name":"Astrana Health, Inc.","ticker":"ASTH","form_type":"8-K","filed_at":"2024-01-26T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Apollo Medical Holdings to rename to Astrana Health; ticker changes to ASTH on Feb 26","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change from Apollo Medical Holdings, Inc. to Astrana Health, Inc. effective Feb 26, 2024.","Ticker symbol on Nasdaq changes from AMEH to ASTH on same date; CUSIP unchanged.","No stockholder vote required; outstanding stock certificates remain valid without exchange.","Certificate of amendment filed with Delaware Secretary of State on Jan 25, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1925820047.521288,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-01-26T23:59:59+00:00|239324"}